23.2.4 Sulfonamides
Pharmacology
Sulfonamides are synthetic pharmaceutical compounds derived from sulfanilamide, discovered by Gerhard Domagk in 1932. These are antimicrobial drugs that can treat bacterial infections by inhibiting folate synthesis, primarily used for urinary tract infections and skin infections. It acts as competitive inhibitors and bacteriostatic antibiotics to inhibit bacterial synthesis of folic acid, which is essential for DNA synthesis and bacterial growth. These are often administered orally but have few side effects like rashes, nausea, photosensitivity and kidney damage.
Mode of Sulfonamides Action
- Bacteriostatic Effect: Sulfonamides do not kill bacteria immediately but inhibit their growth, allowing the body's immune system to destroy them.
- Selective Toxicity: Sulfonamides are selectively toxic to bacteria because of how they handle folate. Bacteria must build this essential vitamin from scratch, whereas humans simply absorb it from food. This allows the drug to starve the bacteria of vital nutrients while leaving human cells untouched."
- Competitive Inhibition: Sulfonamides bind to the enzyme responsible for creating folate, essentially taking para amino benzoic acid pathway (Folate metabolism).
- Combined Therapy: They are often combined with other agents, like trimethoprim, to create a stronger bactericidal effect (killing bacteria).
- Broad Spectrum: They are effective against both Gram-positive and Gram-negative bacteria, often used for urinary tract infections, acne, and respiratory infections.